![[Rishi Pimentel, gChem]](https://cdn.sanity.io/images/0vv8moc6/pharmtech/16bc98940a34f0991f9ca5e7ccbfa6889fec078f-1634x909.jpg?w=350&fit=crop&auto=format)
|Videos|April 27, 2023
Interview with Scorpius BioManufacturing’s Steven Lavezoli
Author(s)Scorpius BioManufacturing
Key Learning Objectives:
- Demonstrate that Scorpius has the expertise to bring large molecule drugs to the clinic
- Make the industry aware we have immediately available capacity
- Explain how Scorpius values the client-CDMO partnership
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
![[Rishi Pimentel, gChem]](https://cdn.sanity.io/images/0vv8moc6/pharmtech/01d391920288b8bd8b751988988b5a6544a6ddaa-1629x908.jpg?w=350&fit=crop&auto=format)
![[Nigel Langley]](https://cdn.sanity.io/images/0vv8moc6/pharmtech/e2c0137d8224aaa1f14c0f1af43b58d21f4541dd-1768x904.jpg?w=350&fit=crop&auto=format)
Trending on Pharmaceutical Technology
1
New Targets for Clinical Trials in the European Union
2
Nuclear Waste to Medicine: The UK’s Lead-212 Strategy for Cancer Care
3
Leveraging AI/ML to Reduce Risk in Drug Development: Part One
4
Shifting from Trial-and-Error to Rational Design Drives Efficiency in Pharmaceutical Formulation
5
